NCT02025439View on ClinicalTrials.gov

Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness

NACompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Traumatic Brain Injury
Interventions
DEVICE

rTMS

DRUG

Amantadine

Trial Locations (2)

60141

Edward Hines, Jr. VA Hospital, Hines

60611

Northwestern Memorial Hospital, Chicago

All Listed Sponsors
lead

Edward Hines Jr. VA Hospital

FED

NCT02025439 - Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness | Biotech Hunter | Biotech Hunter